Incyte Corporation Stock Performance Overview
- Trading session: 24‑hour period ending 08:36 AM Central Europe, Wednesday 21 March 2026.
- Current price: USD 116.62 per share.
- Trading volume (last 24 h): USD 134.8 million.
- Market capitalization: USD 23 billion.
- Shares outstanding: 202.7 million.
- Price change since last month‑end: down 9.15 %.
- 200‑day simple moving average: USD 107.57.
- 52‑week high: USD 132.60 (28 July 2026).
- 52‑week low: USD 84.02 (28 October 2025).
Comparative Performance of Related Stocks (Last 24 h)
| Ticker | Price Change | Current Price (USD) | Market Cap (USD) | P/E Ratio |
|---|---|---|---|---|
| CNP (Centerpoint Energy) | -2.44 % | 40.24 | 26.7 billion | 24.14 |
| WST (West Pharmaceutical Services) | -0.03 % | 388.78 | 27 billion | 48.87 |
| ZM (Zoom Communications) | +3.61 % | 97.46 | 27.5 billion | 8.74 |
| OTIS (Otis Worldwide) | -0.41 % | 72.07 | 27.2 billion | 18.12 |
| KHC (Kraft Heinz) | 0 % | 23.83 | 27.6 billion | – |
Note: The P/E ratio for Kraft Heinz is not provided; the company is noted for its high dividend yield relative to peers.
Company Background
Incyte Corporation is headquartered in Wilmington, Delaware, USA. The company focuses on the discovery, development, and commercialization of proprietary small‑molecule drugs, with a primary emphasis on oncology indications.
